DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Graves JE, Nunley K, Heffernan MP.
Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2).
J Am Acad Dermatol 2007;
56 (01) e55-e79
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.